These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 8612563)

  • 1. Cloning and characterization of human urocortin.
    Donaldson CJ; Sutton SW; Perrin MH; Corrigan AZ; Lewis KA; Rivier JE; Vaughan JM; Vale WW
    Endocrinology; 1996 May; 137(5):2167-70. PubMed ID: 8612563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor.
    Vaughan J; Donaldson C; Bittencourt J; Perrin MH; Lewis K; Sutton S; Chan R; Turnbull AV; Lovejoy D; Rivier C
    Nature; 1995 Nov; 378(6554):287-92. PubMed ID: 7477349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor.
    Lewis K; Li C; Perrin MH; Blount A; Kunitake K; Donaldson C; Vaughan J; Reyes TM; Gulyas J; Fischer W; Bilezikjian L; Rivier J; Sawchenko PE; Vale WW
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7570-5. PubMed ID: 11416224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors.
    Perrin MH; Sutton SW; Cervini LA; Rivier JE; Vale WW
    J Pharmacol Exp Ther; 1999 Feb; 288(2):729-34. PubMed ID: 9918582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urocortin is the principal ligand for the corticotrophin-releasing factor binding protein in the ovine brain with no evidence for a sauvagine-like peptide.
    Baigent SM; Lowry PJ
    J Mol Endocrinol; 2000 Feb; 24(1):53-63. PubMed ID: 10656997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and characterization of corticotropin-releasing factor and urocortin in Syrian hamster (Mesocricetus auratus).
    Robinson BM; Tellam DJ; Smart D; Mohammad YN; Brennand J; Rivier JE; Lovejoy DA
    Peptides; 1999; 20(10):1177-85. PubMed ID: 10573289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urocortins of the South African clawed frog, Xenopus laevis: conservation of structure and function in tetrapod evolution.
    Boorse GC; Crespi EJ; Dautzenberg FM; Denver RJ
    Endocrinology; 2005 Nov; 146(11):4851-60. PubMed ID: 16037378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cloning of a type A chicken corticotropin-releasing factor receptor with high affinity for urotensin I.
    Yu J; Xie LY; Abou-Samra AB
    Endocrinology; 1996 Jan; 137(1):192-7. PubMed ID: 8536612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor.
    Perrin MH; Donaldson CJ; Chen R; Lewis KA; Vale WW
    Endocrinology; 1993 Dec; 133(6):3058-61. PubMed ID: 8243338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and functional pharmacology of two corticotropin-releasing factor receptors from a teleost fish.
    Pohl S; Darlison MG; Clarke WC; Lederis K; Richter D
    Eur J Pharmacol; 2001 Nov; 430(2-3):193-202. PubMed ID: 11711031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
    Grigoriadis DE; Liu XJ; Vaughn J; Palmer SF; True CD; Vale WW; Ling N; De Souza EB
    Mol Pharmacol; 1996 Sep; 50(3):679-86. PubMed ID: 8794910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and function of the ovine type 1 corticotropin releasing factor receptor (CRF1) and a carboxyl-terminal variant.
    Myers DA; Trinh JV; Myers TR
    Mol Cell Endocrinol; 1998 Sep; 144(1-2):21-35. PubMed ID: 9863624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Labelling of CRF1 and CRF2 receptors using the novel radioligand, [3H]-urocortin.
    Gottowik J; Goetschy V; Henriot S; Kitas E; Fluhman B; Clerc RG; Moreau JL; Monsma FJ; Kilpatrick GJ
    Neuropharmacology; 1997 Oct; 36(10):1439-46. PubMed ID: 9423932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors.
    Reyes TM; Lewis K; Perrin MH; Kunitake KS; Vaughan J; Arias CA; Hogenesch JB; Gulyas J; Rivier J; Vale WW; Sawchenko PE
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2843-8. PubMed ID: 11226328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity.
    Hoare SR; Sullivan SK; Fan J; Khongsaly K; Grigoriadis DE
    Peptides; 2005 Mar; 26(3):457-70. PubMed ID: 15652653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-amino acid-substituted analogs of corticotropin-releasing hormone (CRH) and urocortin with selective agonist activity at CRH1 and CRH2beta receptors.
    Wei ET; Thomas HA; Christian HC; Buckingham JC; Kishimoto T
    Peptides; 1998; 19(7):1183-90. PubMed ID: 9786168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of the corticotropin-releasing factor (CRF) type 2 receptor in CRF-induced thyrotropin release by the amphibian pituitary gland.
    Okada R; Miller MF; Yamamoto K; De Groef B; Denver RJ; Kikuyama S
    Gen Comp Endocrinol; 2007 Feb; 150(3):437-44. PubMed ID: 17188689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and characterization of a short variant of the corticotropin-releasing factor receptor subtype from rat amygdala.
    Miyata I; Shiota C; Ikeda Y; Oshida Y; Chaki S; Okuyama S; Inagami T
    Biochem Biophys Res Commun; 1999 Mar; 256(3):692-6. PubMed ID: 10080961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monkey corticotropin-releasing factor1 receptor: Complementary DNA cloning and pharmacological characterization.
    Oshida Y; Ikeda Y; Chaki S; Okuyama S
    Life Sci; 2004 Feb; 74(15):1911-24. PubMed ID: 14761672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The first extracellular domain of corticotropin releasing factor-R1 contains major binding determinants for urocortin and astressin.
    Perrin MH; Sutton S; Bain DL; Berggren WT; Vale WW
    Endocrinology; 1998 Feb; 139(2):566-70. PubMed ID: 9449626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.